JP2015537210A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015537210A5 JP2015537210A5 JP2015541154A JP2015541154A JP2015537210A5 JP 2015537210 A5 JP2015537210 A5 JP 2015537210A5 JP 2015541154 A JP2015541154 A JP 2015541154A JP 2015541154 A JP2015541154 A JP 2015541154A JP 2015537210 A5 JP2015537210 A5 JP 2015537210A5
- Authority
- JP
- Japan
- Prior art keywords
- seprase
- sample
- affinity reagent
- tumor
- target affinity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100009984 FAP Human genes 0.000 claims 11
- 108010072257 fibroblast activation protein alpha Proteins 0.000 claims 11
- 239000003153 chemical reaction reagent Substances 0.000 claims 9
- -1 CK5 Proteins 0.000 claims 7
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims 7
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 210000004027 cells Anatomy 0.000 claims 6
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 claims 5
- 210000004369 Blood Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 229920002395 Aptamer Polymers 0.000 claims 2
- 102100012248 KRT19 Human genes 0.000 claims 2
- 101710026204 KRT19 Proteins 0.000 claims 2
- 102000004965 antibodies Human genes 0.000 claims 2
- 108090001123 antibodies Proteins 0.000 claims 2
- 230000001588 bifunctional Effects 0.000 claims 2
- 230000027455 binding Effects 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 101710041486 ACTR2 Proteins 0.000 claims 1
- 108090001008 Avidin Proteins 0.000 claims 1
- 101700062259 BAT2 Proteins 0.000 claims 1
- 102100013894 BCL2 Human genes 0.000 claims 1
- 108060000885 BCL2 Proteins 0.000 claims 1
- 102100007326 BIRC5 Human genes 0.000 claims 1
- 101700004551 BRAF Proteins 0.000 claims 1
- 102100004328 BRAF Human genes 0.000 claims 1
- 210000001124 Body Fluids Anatomy 0.000 claims 1
- 102100003170 CCL4 Human genes 0.000 claims 1
- 101700040051 CCL4 Proteins 0.000 claims 1
- 108060001249 CD24 Proteins 0.000 claims 1
- 102100000197 CD24 Human genes 0.000 claims 1
- 102100016492 CD34 Human genes 0.000 claims 1
- 108060001251 CD34 Proteins 0.000 claims 1
- 101700078950 CD44 Proteins 0.000 claims 1
- 102100003735 CD44 Human genes 0.000 claims 1
- 101710043956 CEACAM5 Proteins 0.000 claims 1
- 101710043948 CEACAM7 Proteins 0.000 claims 1
- 102100002212 CXCR4 Human genes 0.000 claims 1
- 101710003734 CXCR4 Proteins 0.000 claims 1
- 101710004932 ECU01_0460 Proteins 0.000 claims 1
- 102100009831 EPHB4 Human genes 0.000 claims 1
- 101700032546 EPHB4 Proteins 0.000 claims 1
- 102100016662 ERBB2 Human genes 0.000 claims 1
- 101700025368 ERBB2 Proteins 0.000 claims 1
- 102100009850 ERBB3 Human genes 0.000 claims 1
- 101700041204 ERBB3 Proteins 0.000 claims 1
- 101700010580 FLO11 Proteins 0.000 claims 1
- 102100009279 KRAS Human genes 0.000 claims 1
- 101710033922 KRAS Proteins 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- 101710026102 MIC-ACT-2 Proteins 0.000 claims 1
- 102100006037 MUC1 Human genes 0.000 claims 1
- 101700052761 MUC1 Proteins 0.000 claims 1
- 206010061289 Metastatic neoplasm Diseases 0.000 claims 1
- 102000008789 N-cadherin Human genes 0.000 claims 1
- 108050000637 N-cadherin Proteins 0.000 claims 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N OBO Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims 1
- 102100017157 PROM1 Human genes 0.000 claims 1
- 101700033975 PROM1 Proteins 0.000 claims 1
- 102100002896 PSG2 Human genes 0.000 claims 1
- 101700004495 PSG2 Proteins 0.000 claims 1
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 claims 1
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 claims 1
- 101710037934 QRSL1 Proteins 0.000 claims 1
- 108010002687 Survivin Proteins 0.000 claims 1
- 102100019730 TP53 Human genes 0.000 claims 1
- 101710026335 TP53 Proteins 0.000 claims 1
- 102100004269 TWIST1 Human genes 0.000 claims 1
- 108010083162 Twist-Related Protein 1 Proteins 0.000 claims 1
- 102100014870 VIM Human genes 0.000 claims 1
- 101710032218 VIM Proteins 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000000090 biomarker Substances 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 230000002860 competitive Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000004059 degradation Effects 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 230000002255 enzymatic Effects 0.000 claims 1
- 102000017256 epidermal growth factor-activated receptor activity proteins Human genes 0.000 claims 1
- 108040009258 epidermal growth factor-activated receptor activity proteins Proteins 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000001394 metastastic Effects 0.000 claims 1
- 230000036963 noncompetitive Effects 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- CDXVUROVRIFQMV-UHFFFAOYSA-N oxo(diphenoxy)phosphanium Chemical compound C=1C=CC=CC=1O[P+](=O)OC1=CC=CC=C1 CDXVUROVRIFQMV-UHFFFAOYSA-N 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 239000006228 supernatant Substances 0.000 claims 1
- 238000004114 suspension culture Methods 0.000 claims 1
- 210000004881 tumor cells Anatomy 0.000 claims 1
Claims (17)
- 試料から循環腫瘍細胞を捕捉する方法であって、
i)該試料を、哺乳動物のセプラーゼ標的親和性試薬に接触させること;
ii)該試料を、哺乳動物のEpCAM標的親和性試薬に接触させること;並びに
iii)工程i)およびi)で得た細胞を捕捉することにより、該試料から循環腫瘍細胞を捕捉すること;
を含み、
ここで、セプラーゼ標的親和性試薬およびEpCAM標的親和性試薬は、それぞれ固体支持体の表面に固定されている、方法。 - セプラーゼ標的親和性試薬は、セプラーゼの競合的または非競合的阻害剤である、請求項1に記載の方法。
- セプラーゼ標的親和性試薬は、セプラーゼの抗体、核酸アプタマー、またはペプチドアプタマーまたはペプチドリガンドである、請求項1又は2に記載の方法。
- セプラーゼのペプチドリガンドは、Ac−Gly−プロリンボロン酸(Ac−Gly−BoroPro)およびプロリンジフェニルホスホネート(Gly−ProP(OPh)2)から選択される、請求項3に記載の方法。
- EpCAM標的親和性試薬は、抗体である、請求項1に記載の方法。
- セプラーゼ標的親和性試薬およびEpCAM標的親和性試薬を、連続的または同時に施す、請求項1に記載の方法。
- 固体支持体が、マイクロ流体デバイスの一部である、請求項1に記載の方法。
- 捕捉された循環腫瘍細胞を放出する工程を更に含む、請求項1〜7のいずれか1項に記載の方法。
- 放出は、過剰量の可溶性セプラーゼ結合剤の添加、アビジン化合物の添加、あるいは二官能性リンカーの光開裂または酵素分解により行われる、請求項8に記載の方法。
- 前記二官能性リンカーは、酵素的または化学的に切断可能な部位を有する、請求項9に記載の方法。
- 前記試料は、腫瘍試料または腫瘍を有する患者の血液試料である、請求項1〜10のいずれか1項に記載の方法。
- 捕捉された細胞上でセプラーゼおよびEpCAMを検出することを更に含む、請求項1〜11のいずれか1項に記載の方法。
- EpCAMを発現する細胞に対するセプラーゼを発現する細胞の比率を決定することを更に含む、請求項1〜12のいずれか1項に記載の方法。
- 請求項1に記載の方法で患者試料から循環腫瘍細胞を捕捉することにより、患者における悪性腫瘍の存在を検出する方法。
- 請求項1に記載の方法で患者試料から循環腫瘍細胞を捕捉することにより、腫瘍を保有しているかまたは保有していた患者において転移性腫瘍を発症するリスクを評価する方法。
- 前記患者試料は、全血、体液、任意の細胞含有血液画分、腫瘍断片、腫瘍細胞懸濁液、または患者試料から樹立した細胞培養物、もしくは該培養物の上清、または患者の腫瘍から樹立した異種移植片を含む、請求項14または15に記載の方法。
- 捕捉された細胞において、EpCAM、CD146、CK5、CK7、CK18、CK19、CD44、Cd44v6、EphB4、IGF−1R、BCL2、HER2、HER3、CA19−9、CEA、CD133、MUC1、N−カドヘリン、サバイビン、EGFR、KRAS、BRAF、p53、Pi3KCA、PTEN、KRT19、CD34、CD24、ACT2、VIM、NANOG、CXCR4およびTWIST1のうち1つまたは複数のバイオマーカーを検出する工程を更に含む、請求項1または5に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261724753P | 2012-11-09 | 2012-11-09 | |
US61/724,753 | 2012-11-09 | ||
PCT/EP2013/073381 WO2014072465A1 (en) | 2012-11-09 | 2013-11-08 | In vitro capture and analysis of circulating tumor cells |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015537210A JP2015537210A (ja) | 2015-12-24 |
JP2015537210A5 true JP2015537210A5 (ja) | 2016-12-15 |
JP6404824B2 JP6404824B2 (ja) | 2018-10-17 |
Family
ID=49582733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015541154A Active JP6404824B2 (ja) | 2012-11-09 | 2013-11-08 | 循環腫瘍細胞のインビトロでの捕捉および解析 |
Country Status (7)
Country | Link |
---|---|
US (2) | US9250242B2 (ja) |
EP (1) | EP2919910B1 (ja) |
JP (1) | JP6404824B2 (ja) |
CN (1) | CN104781007B (ja) |
CA (1) | CA2891028C (ja) |
ES (1) | ES2660438T3 (ja) |
WO (1) | WO2014072465A1 (ja) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10155988B2 (en) * | 2010-04-07 | 2018-12-18 | Board Of Regents, The University Of Texas System | Methods of detecting tumor cells |
TWI539158B (zh) * | 2010-06-08 | 2016-06-21 | 維里德克斯有限責任公司 | 使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。 |
US10130946B2 (en) | 2011-09-30 | 2018-11-20 | The Regents Of The University Of Michigan | System for detecting rare cells |
US9645149B2 (en) | 2011-09-30 | 2017-05-09 | The Regents Of The University Of Michigan | System for detecting rare cells |
WO2014070776A1 (en) | 2012-10-29 | 2014-05-08 | The Regents Of The University Of Michigan | Microfluidic device and method for detecting rare cells |
WO2014072465A1 (en) | 2012-11-09 | 2014-05-15 | Roche Diagnostics Gmbh | In vitro capture and analysis of circulating tumor cells |
EP2799872B1 (en) * | 2013-05-01 | 2017-10-18 | F. Hoffmann-La Roche AG | Selective release of sub-group of biological units |
US9709556B2 (en) | 2013-12-11 | 2017-07-18 | Analiza, Inc. | Devices and methods for determining and/or isolating circulating cancer cells |
US20150160246A1 (en) | 2013-12-11 | 2015-06-11 | Analiza, Inc. | Devices and methods for determining and/or isolating cells such as circulating cancer or fetal cells |
US10829804B2 (en) | 2015-03-23 | 2020-11-10 | The University Of North Carolina At Chapel Hill | Method for identification and enumeration of nucleic acid sequences, expression, splice variant, translocation, copy, or DNA methylation changes using combined nuclease, ligase, polymerase, terminal transferase, and sequencing reactions |
US10393726B2 (en) | 2015-03-23 | 2019-08-27 | The University Of North Carolina At Chapel Hill | Universal molecular processor for precision medicine |
US10317406B2 (en) | 2015-04-06 | 2019-06-11 | The Regents Of The University Of Michigan | System for detecting rare cells |
CN105259096B (zh) * | 2015-10-19 | 2018-01-12 | 武汉顺可达生物科技有限公司 | 磷酸锌纳米基底及其制备方法和在循环肿瘤细胞捕获与释放中的应用 |
CN106868098A (zh) | 2015-12-10 | 2017-06-20 | 益善生物技术股份有限公司 | 循环肿瘤细胞分型鉴定试剂盒 |
CN108884445A (zh) | 2016-03-09 | 2018-11-23 | 北京智康博药肿瘤医学研究有限公司 | 肿瘤细胞悬浮培养物和相关方法 |
JPWO2017188346A1 (ja) * | 2016-04-27 | 2019-02-28 | 国立大学法人 東京大学 | マイクロファイバーを用いた血中循環細胞の捕捉及び回収用材料及び当該材料を用いる方法 |
WO2017199651A1 (ja) * | 2016-05-18 | 2017-11-23 | ソニー株式会社 | 生体物質分析装置、生体物質分析システム、生体物質選別方法、生体物質分析用プログラム及び細胞培養容器 |
WO2017205267A1 (en) | 2016-05-22 | 2017-11-30 | Cornell University | Multifunctional microfluidic device for capturing target cells and analyzing genomic dna isolated from the target cells while under flow conditions |
CN107475355A (zh) * | 2016-06-08 | 2017-12-15 | 益善生物技术股份有限公司 | 肺癌早期筛查试剂盒 |
CN107475354A (zh) * | 2016-06-08 | 2017-12-15 | 益善生物技术股份有限公司 | 前列腺癌组织溯源ctc分型鉴定试剂盒 |
CN106366197B (zh) * | 2016-08-31 | 2021-03-30 | 上海美吉生物医药科技有限公司 | 一种HER2、EGFR、EpCAM、MUC1多重抗体免疫磁珠及其制备方法 |
CN106434904A (zh) * | 2016-09-07 | 2017-02-22 | 上海交通大学医学院附属仁济医院 | 一种实时监控肝癌复发或转移的CD133、EpCAM和CK19联合检测试剂盒 |
WO2018111989A1 (en) | 2016-12-14 | 2018-06-21 | Purdue Research Foundation | Fibroblast activation protein (fap)-targeted imaging and therapy |
JPWO2018116465A1 (ja) * | 2016-12-22 | 2019-10-24 | 日立化成株式会社 | Her2陽性癌細胞の検出方法 |
CN106866820B (zh) * | 2017-02-17 | 2020-04-03 | 艾比玛特医药科技(上海)有限公司 | 一种用于捕获肿瘤细胞的抗人角蛋白18的单克隆抗体及其应用 |
EP3601198A4 (en) * | 2017-03-30 | 2021-01-13 | The Board of Trustees of the University of Illinois | METHOD AND KIT FOR DIAGNOSING Pancreatic Gland Cancer In EARLY STAGE |
CN108344615B (zh) * | 2018-01-24 | 2020-10-23 | 杭州安弼晟生物科技有限公司 | 一种循环肿瘤细胞捕获系统及控制方法 |
WO2020086761A1 (en) * | 2018-10-24 | 2020-04-30 | Path Ex, Inc. | Method for the capture and isolation of disease material from flowing matter |
WO2020139211A1 (en) | 2018-12-28 | 2020-07-02 | Mikro Biyosistemler Elektronik Sanayi Ve Ticaret A.S. | A microfluidic device for selective capture of biological entities |
CN110082529B (zh) * | 2019-03-11 | 2022-04-19 | 南方医科大学深圳医院 | 一种肿瘤细胞表面标志物及其应用 |
CN112143732B (zh) * | 2019-06-28 | 2022-03-22 | 中国科学院苏州纳米技术与纳米仿生研究所 | 特异性识别N-cadherin的ssDNA适配体、其筛选方法及应用 |
US20230242983A1 (en) * | 2020-07-06 | 2023-08-03 | Sony Group Corporation | Bioparticle analysis method and bioparticle analysis system |
CN112569362B (zh) * | 2020-12-23 | 2022-05-17 | 北京航空航天大学 | 一种通过打散ctc细胞团抑制肿瘤转移的方法 |
CN112924363A (zh) * | 2021-01-22 | 2021-06-08 | 中国科学院苏州纳米技术与纳米仿生研究所 | 中间型循环肿瘤细胞作为肿瘤诊断和预后标志物及其应用 |
EP4284911A1 (en) * | 2021-01-27 | 2023-12-06 | BioFluidica, Inc. | High efficiency capture of fetal cells from maternal samples |
CN112730840B (zh) * | 2021-01-29 | 2023-10-17 | 章毅 | 鉴别cd44和cd24分子表型的方法 |
CN114874989B (zh) * | 2022-04-11 | 2024-06-25 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种循环肿瘤细胞捕获方法 |
WO2024021040A1 (zh) * | 2022-07-29 | 2024-02-01 | 曾繁根 | 细胞辨识方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9907852A (pt) * | 1998-02-12 | 2000-10-24 | Immunivest Corp | Processos para detectar e enumerar células raras e cancerosas em uma população celular mista, para diagnosticar câncer de estágio precoce em um paciente de teste, para determinar a probabilidade de recorrência de câncer em um paciente humano anteriormente tratado de câncer, para distinguir um carcinoma confinado ao órgão de um carcinoma com propriedades metastáticas, para acompanhar a situação de remissão em um paciente humano com câncer que passa pelo tratamento de terapia contra o câncer e para aumentar quantidades de células epiteliais circulantes em uma amostra de sangue, partìcula magnética revestida, composição, conjuntos de teste para avaliar uma amostra de paciente quanto a presença de células raras circulantes, quanto a presença de células de tumor circulantes, quanto a presença de células de câncer de mama circulantes, quanto a presença de células de câncer de próstata circulantes, quanto a presença de células de câncer de cólon circulantes, quanto a presença de células de câncer de bexiga circulantes e para monitorar um paciente quanto a recorrência de câncer, e, fração de sangue periférico enriquecido quanto a células neoplásticas circulantes |
EP1315829B1 (en) | 2000-09-09 | 2010-07-28 | The Research Foundation Of State University Of New York | Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof |
CN1922304A (zh) * | 2003-10-31 | 2007-02-28 | 维特克公司 | 用于检测循环肿瘤和内皮细胞的血液测试样机和方法 |
WO2008131035A2 (en) * | 2007-04-16 | 2008-10-30 | Cellpoint Diagnotics, Inc. | Methods for diagnosing, prognosing, or theranosing a condition using rare cells |
EP2201134B1 (en) | 2007-09-19 | 2018-11-21 | The Research Foundation of State University of New York | Gene expression signatures in enriched tumor cell samples |
BRPI0820793A2 (pt) | 2007-12-10 | 2015-06-16 | Hoffmann La Roche | Seprase como marcador de câncer |
EP2291509B1 (en) | 2008-05-16 | 2023-11-15 | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | Microfluidic isolation of tumor cells or other rare cells from whole blood or other liquids |
GR1006582B (el) | 2008-07-14 | 2009-11-03 | Ελενη Στυλιανου Μωυσιαδου | Προϊοντα καθαρισμου και απολυμανσης με φυσικα αβλαβη υλικα που εχουν βαση την ζαχαρη |
US20100210989A1 (en) * | 2008-12-23 | 2010-08-19 | Janet Lesley Macpherson | Processing blood |
WO2010108003A2 (en) * | 2009-03-18 | 2010-09-23 | The Regents Of The University Of California | Device for capturing circulating cells |
EP2411808B1 (en) | 2009-03-24 | 2015-11-11 | Biocept, Inc. | Devices and methods of cell capture and analysis |
WO2010124227A2 (en) | 2009-04-24 | 2010-10-28 | The Board Of Trustees Of The University Of Illinois | Methods and devices for capturing circulating tumor cells |
EP2670856B1 (en) | 2011-02-03 | 2018-06-27 | Northeastern University | Methods and compositions for highly specific capture and release of biological materials |
CN202279815U (zh) * | 2011-07-19 | 2012-06-20 | 西门子公司 | 循环肿瘤细胞捕获装置 |
WO2014072465A1 (en) | 2012-11-09 | 2014-05-15 | Roche Diagnostics Gmbh | In vitro capture and analysis of circulating tumor cells |
-
2013
- 2013-11-08 WO PCT/EP2013/073381 patent/WO2014072465A1/en active Application Filing
- 2013-11-08 ES ES13789770.8T patent/ES2660438T3/es active Active
- 2013-11-08 EP EP13789770.8A patent/EP2919910B1/en active Active
- 2013-11-08 CA CA2891028A patent/CA2891028C/en active Active
- 2013-11-08 US US14/075,143 patent/US9250242B2/en active Active
- 2013-11-08 CN CN201380058487.2A patent/CN104781007B/zh active Active
- 2013-11-08 JP JP2015541154A patent/JP6404824B2/ja active Active
-
2015
- 2015-12-18 US US14/975,230 patent/US9952212B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015537210A5 (ja) | ||
WO2012056407A8 (en) | Antibodies which bind soluble t-cell receptor ligands | |
Hou et al. | Polymer nanofiber‐embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells | |
JP6404824B2 (ja) | 循環腫瘍細胞のインビトロでの捕捉および解析 | |
MX2013004172A (es) | Metodos y kits para la deteccion de células tumorales circulantes en pacientes pancreáticos por medio del uso de captura poliespecífica y reactivos de detección de cocteles. | |
EA201590671A1 (ru) | Комбинация антител к kir и антител к pd-1 для лечения злокачественной опухоли | |
Shi et al. | Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles | |
JP2014521958A5 (ja) | ||
Liu et al. | Circulating tumor cells in prostate cancer: Precision diagnosis and therapy | |
WO2012045012A3 (en) | Sandwich assays in droplets | |
EA201390638A8 (ru) | Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения | |
RU2013142170A (ru) | Связанные со стрептавидином магнитные частицы и способ их изготовления | |
DE602005009819D1 (de) | Verfahren zum nachweis von infektionen mit mykobakterien | |
JP2013174612A5 (ja) | ||
MY172290A (en) | Immunochromatography devices, methods, and, kits | |
MX2010004251A (es) | Anticuerpo anti-bst2. | |
WO2006034278A3 (en) | Methods and compositions for detecting cancer using components of the u2 spliceosomal particle | |
JP2012073260A5 (ja) | ||
MX349661B (es) | Metodo para la deteccion de una molecula de union de un enlazador multiespecifico. | |
JP2015502547A5 (ja) | ||
WO2012129423A3 (en) | Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics | |
WO2012159072A3 (en) | Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins | |
US20120142089A1 (en) | Method of separating target cell in biological sample | |
Wu et al. | Extracellular vesicles in urologic malignancies—Implementations for future cancer care | |
JP2015508500A5 (ja) |